Welcome to our dedicated page for BioScience Health Innovations news (Ticker: BHIC), a resource for investors and traders seeking the latest updates and insights on BioScience Health Innovations stock.
BioScience Health Innovations reports company developments tied to Best 365 Labs, its wholly owned subsidiary focused on science-backed cellular health, NAD and mitochondrial optimization. Recent news centers on e-commerce commercialization, Amazon marketplace operations, retail-channel infrastructure and partnerships that support the subsidiary’s consumer health and wellness products.
BHIC news also includes public-company context such as OTC trading status, subsidiary-level growth initiatives and corporate updates connected to the company’s health and wellness operating profile.
Bioscience Health Innovations (OTC: BHIC) announced that Best 365 Labs, its wholly owned subsidiary, has partnered with Rebelution and Growvana to run and scale its Amazon operations beginning March 12, 2026. The agreement centralizes Amazon commercialization, storefront optimization, content execution, and operational infrastructure to support BHIC's push toward a major exchange uplist.
Best 365 Labs markets MODS Max™, a proprietary bioavailability platform across 30 patent-pending formulations targeting NAD, hormonal optimization, sleep, tissue repair, metabolic health, and longevity; the company cites >5,000 patient-uses with no serious adverse events reported.